The global Next-Generation Sequencing Market is experiencing significant growth as healthcare providers, research institutions, and biotechnology companies increasingly adopt advanced genomic technologies. Next-generation sequencing (NGS) enables researchers to analyze large amounts of genetic information quickly and efficiently. It plays an important role in disease diagnosis, cancer research, drug discovery, personalized medicine, and genetic testing.
According to Fortune Business Insights, the global Next-Generation Sequencing Market size was valued at USD 10.44 billion in 2025. The market is projected to grow from USD 11.79 billion in 2026 to USD 38.34 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 15.88% during the forecast period. Increasing demand for precision medicine, advancements in genomic technologies, and rising investments in genetic research are expected to support market expansion.
The increasing adoption of personalized medicine is a major factor driving the Next-Generation Sequencing Market. Traditional treatment approaches often follow standardized methods, whereas personalized medicine uses individual genetic information to guide treatment decisions. NGS helps healthcare professionals identify genetic variations that may influence disease development and treatment responses.
The technology is particularly important in oncology, where genomic analysis can help identify mutations associated with different cancer types. Growing interest in targeted therapies and individualized treatment strategies is encouraging healthcare providers to incorporate genomic testing into clinical practice.
The rising global burden of cancer and inherited diseases is creating opportunities for NGS technologies. Researchers use sequencing methods to study genetic mutations, identify disease-associated biomarkers, and understand biological changes linked to different medical conditions.
NGS is also increasingly used for reproductive health testing, rare disease diagnosis, infectious disease research, and population genomics. Its ability to analyze multiple genes simultaneously makes it valuable for applications requiring comprehensive genetic information. Continued research and improvements in sequencing accuracy may further expand its clinical and scientific applications.
For detailed market insights : https://www.fortunebusinessinsights.com/industry-reports/next-generation-sequencing-ngs-market-101000
Based on technology, the Next-Generation Sequencing Market includes sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and other technologies.
The market includes sequencing platforms, consumables, and services. Sequencing platforms are essential instruments used to process genetic samples and generate sequencing data. Improvements in instrument performance, throughput, and automation are influencing purchasing decisions among laboratories and research institutions.
Consumables, including reagents, flow cells, and sample preparation materials, represent an important part of sequencing operations. Meanwhile, sequencing services support organizations that do not have the infrastructure or expertise required to conduct genomic analysis internally. Growing outsourcing activities may create additional opportunities for specialized service providers.